Dave Selkirk is President of Ergomed Clinical Research, with over 32 years of leadership experience in the biotech and pharmaceutical industry. With a strong pedigree in Alliance Management, Dave is passionate about bridging the gap between sponsors and Ergomed to partner for clinical trial success.
He joined Ergomed in 2023 as Executive Vice President of Global Operations. Before Ergomed, Dave held executive positions at CROs, including Covance (LabCorp Drug Development) and Paraxel. For the first decade of his career, Dave worked on the sponsor side of the clinical trial industry in various cross-functional operational roles for pharma/biotech companies. Through his long career, Dave has built significant experience in clinical trial design across the gamut of disease indications and phases of research. He also has extensive experience in post-marketing research/RWE, both central and esoteric laboratory services, preclinical research, bioanalysis, as well as technology platforms to support both data accuracy and patient centricity,
As president, Dave has underpinned Ergomed’s significant North American presence in support of oncology, rare disease, and complex clinical trial research. He applies his vision for partnering with biotech and pharma sponsors to deliver best-in-class strategic solutions.
